Publication

Publication Year
PMID
Title
Authors
Citation
First Author
Journal/Book
DOI
202438982642GLDADec: marker-gene guided LDA modeling for bulk gene expression deconvolutionAzuma I, Mizuno T, Kusuhara H.Brief Bioinform. 2024 May 23;25(4):bbae315. doi: 10.1093/bib/bbae315.Azuma IBrief Bioinform10.1093/bib/bbae315
202438187088Investigation of the usefulness of liver-specific deconvolution method by establishing a liver benchmark datasetAzuma I, Mizuno T, Morita K, Suzuki Y, Kusuhara H.NAR Genom Bioinform. 2024 Jan 5;6(1):lqad111. doi: 10.1093/nargab/lqad111. eCollection 2024 Mar.Azuma INAR Genom Bioinform10.1093/nargab/lqad111
202438140707Thioester-Based Coupled Fluorogenic Assays in Microdevice for the Detection of Single-Molecule Enzyme Activities of Esterases with Specified Substrate RecognitionUkegawa T, Komatsu T, Minoda M, Matsumoto T, Iwasaka T, Mizuno T, Tachibana R, Sakamoto S, Hanaoka K, Kusuhara H, Honda K, Watanabe R, Urano Y.Adv Sci (Weinh). 2024 Mar;11(10):e2306559. doi: 10.1002/advs.202306559. Epub 2023 Dec 22.Ukegawa TAdv Sci (Weinh)10.1002/advs.202306559
202438365821Difficulty in chirality recognition for Transformer architectures learning chemical structures from string representationsYoshikai Y, Mizuno T, Nemoto S, Kusuhara H.Nat Commun. 2024 Feb 16;15(1):1197. doi: 10.1038/s41467-024-45102-8.Yoshikai YNat Commun10.1038/s41467-024-45102-8
202438341604Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2Kondou H, Nakano S, Mizuno T, Bessho K, Hasegawa Y, Nakazawa A, Tanikawa K, Azuma Y, Okamoto T, Inui A, Imagawa K, Kasahara M, Zen Y, Suzuki M, Hayashi H.Orphanet J Rare Dis. 2024 Feb 10;19(1):57. doi: 10.1186/s13023-024-03080-6.Kondou HOrphanet J Rare Dis10.1186/s13023-024-03080-6
202438218189Identification of activity-based biomarkers for early-stage pancreatic tumors in blood using single-molecule enzyme activity screeningSakamoto S, Hiraide H, Minoda M, Iwakura N, Suzuki M, Ando J, Takahashi C, Takahashi I, Murai K, Kagami Y, Mizuno T, Koike T, Nara S, Morizane C, Hijioka S, Kashiro A, Honda K, Watanabe R, Urano Y, Komatsu T.Cell Rep Methods. 2024 Jan 22;4(1):100688. doi: 10.1016/j.crmeth.2023.100688. Epub 2024 Jan 12.Sakamoto SCell Rep Methods10.1016/j.crmeth.2023.100688
202438825484Investigation of normalization procedures for transcriptome profiles of compounds oriented toward practical study designMizuno T, Kusuhara H.J Toxicol Sci. 2024;49(6):249-259. doi: 10.2131/jts.49.249.Mizuno TJ Toxicol Sci10.2131/jts.49.249
202438016375Investigation of latent representation of toxicopathological images extracted by CNN model for understanding compound properties in vivoMaedera S, Mizuno T, Kusuhara H.Comput Biol Med. 2024 Jan;168:107748. doi: 10.1016/j.compbiomed.2023.107748. Epub 2023 Nov 23.Maedera SComput Biol Med10.1016/j.compbiomed.2023.107748
202337990006Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitisTamura R, Sabu Y, Mizuno T, Mizuno S, Nakano S, Suzuki M, Abukawa D, Kaji S, Azuma Y, Inui A, Okamoto T, Shimizu S, Fukuda A, Sakamoto S, Kasahara M, Takahashi S, Kusuhara H, Zen Y, Ando T, Hayashi H.Nat Commun. 2023 Nov 21;14(1):6763. doi: 10.1038/s41467-023-42424-x.Tamura RNat Commun10.1038/s41467-023-42424-x
202337941435Rat Deconvolution as Knowledge Miner for Immune Cell Trafficking from Toxicogenomics DatabasesMorita K, Mizuno T, Azuma I, Suzuki Y, Kusuhara H.Toxicol Sci. 2023 Nov 6;197(2):121-31. doi: 10.1093/toxsci/kfad117. Online ahead of print.Morita KToxicol Sci10.1093/toxsci/kfad117
202337046349Investigation of chemical structure recognition by encoder-decoder models in learning progressNemoto S, Mizuno T, Kusuhara H.J Cheminform. 2023 Apr 12;15(1):45. doi: 10.1186/s13321-023-00713-z.Nemoto SJ Cheminform10.1186/s13321-023-00713-z
202336915410Characterization of proteome profile data of chemicals based on data-independent acquisition MS with SWATH methodIshiguro H, Mizuno T, Uchida Y, Sato R, Sasaki H, Nemoto S, Terasaki T, Kusuhara H.NAR Genom Bioinform. 2023 Mar 11;5(1):lqad022. doi: 10.1093/nargab/lqad022. eCollection 2023 Mar.Ishiguro HNAR Genom Bioinform10.1093/nargab/lqad022
202336635231NRBdMF: A Recommendation Algorithm for Predicting Drug Effects Considering DirectionalityAzuma I, Mizuno T, Kusuhara H.J Chem Inf Model. 2023 Jan 23;63(2):474-483. doi: 10.1021/acs.jcim.2c01210. Epub 2023 Jan 12.Azuma IJ Chem Inf Model10.1021/acs.jcim.2c01210
202336724926[Understanding of Multiple Effects of Low Molecular Weight Compounds with Factor Analysis]Mizuno T, Nemoto S, Morita K, Kusuhara H.Yakugaku Zasshi. 2023;143(2):127-132. doi: 10.1248/yakushi.22-00156-2.Mizuno TYakugaku Zasshi10.1248/yakushi.22-00156-2
202235971760Investigation of a Data Split Strategy Involving the Time Axis in Adverse Event Prediction Using Machine LearningMorita K, Mizuno T, Kusuhara H.J Chem Inf Model. 2022 Sep 12;62(17):3982-3992. doi: 10.1021/acs.jcim.2c00765. Epub 2022 Aug 16.Morita KJ Chem Inf Model10.1021/acs.jcim.2c00765
202235292967Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug InteractionsMochizuki T, Zamek-Gliszczynski MJ, Yoshida K, Mao J, Taskar K, Hirabayashi H, Chu X, Lai Y, Takashima T, Rockich K, Yamaura Y, Fujiwara K, Mizuno T, Maeda K, Furihata K, Sugiyama Y, Kusuhara H.Clin Pharmacol Ther. 2022 Jun;111(6):1315-1323. doi: 10.1002/cpt.2584. Epub 2022 Apr 11.Mochizuki TClin Pharmacol Ther10.1002/cpt.2584
202236184442[Development of Decomposition Approach for Comprehensive Understanding of Drug Effects]Mizuno T.Yakugaku Zasshi. 2022;142(10):1077-1082. doi: 10.1248/yakushi.22-00123.Mizuno TYakugaku Zasshi10.1248/yakushi.22-00123
202134522617Influence of food on pharmacokinetics and pharmacodynamics of 4-phenylbutyrate in patients with urea cycle disordersNakajima Y, Osaka S, Mizuno T, Yokoi K, Nakano S, Hirai S, Hiraoka Y, Miura Y, Suzuki M, Kusuhara H, Hayashi H.Mol Genet Metab Rep. 2021 Sep 4;29:100799. doi: 10.1016/j.ymgmr.2021.100799. eCollection 2021 Dec.Nakajima YMol Genet Metab Rep10.1016/j.ymgmr.2021.100799
202133836128Decomposition Profile Data Analysis for Deep Understanding of Multiple Effects of Natural ProductsNemoto S, Morita K, Mizuno T, Kusuhara H.J Nat Prod. 2021 Apr 23;84(4):1283-1293. doi: 10.1021/acs.jnatprod.0c01381. Epub 2021 Apr 9.Nemoto SJ Nat Prod10.1021/acs.jnatprod.0c01381
202133648834A randomized trial to examine the impact of food on pharmacokinetics of 4-phenylbutyrate and change in amino acid availability after a single oral administration of sodium 4-phenylbutyrarte in healthy volunteersOsaka S, Nakano S, Mizuno T, Hiraoka Y, Minowa K, Hirai S, Mizutani A, Sabu Y, Miura Y, Shimizu T, Kusuhara H, Suzuki M, Hayashi H.Mol Genet Metab. 2021 Apr;132(4):220-226. doi: 10.1016/j.ymgme.2021.02.002. Epub 2021 Feb 23.Osaka SMol Genet Metab10.1016/j.ymgme.2021.02.002
202133461054Current progress in identifying endogenous biomarker candidates for drug transporter phenotyping and their potential application to drug developmentMochizuki T, Mizuno T, Maeda K, Kusuhara H.Drug Metab Pharmacokinet. 2021 Apr;37:100358. doi: 10.1016/j.dmpk.2020.09.003. Epub 2020 Sep 22.Mochizuki TDrug Metab Pharmacokinet10.1016/j.dmpk.2020.09.003
202133144341Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain BarrierMochizuki T, Mizuno T, Kurosawa T, Yamaguchi T, Higuchi K, Tega Y, Nozaki Y, Kawabata K, Deguchi Y, Kusuhara H.Drug Metab Dispos. 2021 Jan;49(1):3-11. doi: 10.1124/dmd.120.000115. Epub 2020 Nov 3.Mochizuki TDrug Metab Dispos10.1124/dmd.120.000115
202032753643Decomposition profile data analysis of multiple drug effects identifies endoplasmic reticulum stress-inducing ability as an unrecognized factorMorita K, Mizuno T, Kusuhara H.Sci Rep. 2020 Aug 4;10(1):13139. doi: 10.1038/s41598-020-70140-9.Morita KSci Rep10.1038/s41598-020-70140-9
202032114508Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with PaclitaxelMori D, Ishida H, Mizuno T, Kusumoto S, Kondo Y, Izumi S, Nakata G, Nozaki Y, Maeda K, Sasaki Y, Fujita KI, Kusuhara H.Drug Metab Dispos. 2020 May;48(5):387-394. doi: 10.1124/dmd.119.089474. Epub 2020 Feb 29.Mori DDrug Metab Dispos10.1124/dmd.119.089474
202032999153Interesting Properties of Profile Data Analysis in the Understanding and Utilization of the Effects of DrugsMizuno T, Morita K, Kusuhara H.Biol Pharm Bull. 2020;43(10):1435-1442. doi: 10.1248/bpb.b20-00301.Mizuno TBiol Pharm Bull10.1248/bpb.b20-00301
201931511257Elucidation of N (1)-methyladenosine as a Potential Surrogate Biomarker for Drug Interaction Studies Involving Renal Organic Cation TransportersMiyake T, Mizuno T, Takehara I, Mochizuki T, Kimura M, Matsuki S, Irie S, Watanabe N, Kato Y, Ieiri I, Maeda K, Ando O, Kusuhara H.Drug Metab Dispos. 2019 Nov;47(11):1270-1280. doi: 10.1124/dmd.119.087262. Epub 2019 Sep 11.Miyake TDrug Metab Dispos10.1124/dmd.119.087262
201930755704Development of Orthogonal Linear Separation Analysis (OLSA) to Decompose Drug Effects into Basic ComponentsMizuno T, Kinoshita S, Ito T, Maedera S, Kusuhara H.Sci Rep. 2019 Feb 12;9(1):1824. doi: 10.1038/s41598-019-38528-4.Mizuno TSci Rep10.1038/s41598-019-38528-4
201930528339Investigation of non-linear Mate1-mediated efflux of trimethoprim in the mouse kidney as the mechanism underlying drug-drug interactions between trimethoprim and organic cations in the kidneyKito T, Ito S, Mizuno T, Maeda K, Kusuhara H.Drug Metab Pharmacokinet. 2019 Feb;34(1):87-94. doi: 10.1016/j.dmpk.2018.08.005. Epub 2018 Sep 20.Kito TDrug Metab Pharmacokinet10.1016/j.dmpk.2018.08.005
201931787721Development of a Novel Platform of Proteome Profiling Based on an Easy-to-Handle and Informative 2D-DIGE SystemKinoshita S, Mizuno T, Hori M, Kohno M, Kusuhara H.Biol Pharm Bull. 2019;42(12):2069-2075. doi: 10.1248/bpb.b19-00571.Kinoshita SBiol Pharm Bull10.1248/bpb.b19-00571
201930431159GLUT6 is a lysosomal transporter that is regulated by inflammatory stimuli and modulates glycolysis in macrophagesMaedera S, Mizuno T, Ishiguro H, Ito T, Soga T, Kusuhara H.FEBS Lett. 2019 Jan;593(2):195-208. doi: 10.1002/1873-3468.13298. Epub 2018 Dec 4.Maedera SFEBS Lett10.1002/1873-3468.13298
201830154106Evaluation of Organic Anion Transporter 1A2-knock-in Mice as a Model of Human Blood-brain BarrierSano Y, Mizuno T, Mochizuki T, Uchida Y, Umetsu M, Terasaki T, Kusuhara H.Drug Metab Dispos. 2018 Nov;46(11):1767-1775. doi: 10.1124/dmd.118.081877. Epub 2018 Aug 28.Sano YDrug Metab Dispos10.1124/dmd.118.081877
201829531265Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivoKuwahara H, Song J, Shimoura T, Yoshida-Tanaka K, Mizuno T, Mochizuki T, Zeniya S, Li F, Nishina K, Nagata T, Ito S, Kusuhara H, Yokota T.Sci Rep. 2018 Mar 12;8(1):4377. doi: 10.1038/s41598-018-22577-2.Kuwahara HSci Rep10.1038/s41598-018-22577-2
201728479364Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxideMiyake T, Mizuno T, Mochizuki T, Kimura M, Matsuki S, Irie S, Ieiri I, Maeda K, Kusuhara H.J Pharm Sci. 2017 Sep;106(9):2542-2550. doi: 10.1016/j.xphs.2017.04.067. Epub 2017 May 4.Miyake TJ Pharm Sci10.1016/j.xphs.2017.04.067
201525838426Cellular Cholesterol Accumulation Facilitates Ubiquitination and Lysosomal Degradation of Cell Surface-Resident ABCA1Mizuno T, Hayashi H, Kusuhara H.Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1347-56. doi: 10.1161/ATVBAHA.114.305182. Epub 2015 Apr 2.Mizuno TArterioscler Thromb Vasc Biol10.1161/ATVBAHA.114.305182
201424378332Differential roles of ubiquitination in the degradation mechanism of cell surface-resident bile salt export pump and multidrug resistance-associated protein 2Aida K, Hayashi H, Inamura K, Mizuno T, Sugiyama Y.Mol Pharmacol. 2014 Mar;85(3):482-91. doi: 10.1124/mol.113.091090. Epub 2013 Dec 30.Aida KMol Pharmacol10.1124/mol.113.091090
2012222459014-Phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentrationHayashi H, Mizuno T, Horikawa R, Nagasaka H, Yabuki T, Takikawa H, Sugiyama Y.J Hepatol. 2012 May;56(5):1136-1144. doi: 10.1016/j.jhep.2011.11.021. Epub 2012 Jan 13.Hayashi HJ Hepatol10.1016/j.jhep.2011.11.021
201121520210Ubiquitination is associated with lysosomal degradation of cell surface-resident ATP-binding cassette transporter A1 (ABCA1) through the endosomal sorting complex required for transport (ESCRT) pathwayMizuno T, Hayashi H, Naoi S, Sugiyama Y.Hepatology. 2011 Aug;54(2):631-43. doi: 10.1002/hep.24387. Epub 2011 Jun 26.Mizuno THepatology10.1002/hep.24387